Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Biosensors
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Prototype sweat sensor developed to detect medical conditions
Human sweat comes in different forms which contain biomarkers that could assist doctors in making health diagnoses.
February 27, 2023
Probe measures cell stiffness and traction
Seeking ways to alter the probe's mechanical characteristics after injecting it into a tissue of interest, the researchers settled on hydrogels made of polyethylene glycol, a material approved for human use.
January 25, 2023
Saliva-based graphene sensor shows high sensitivity in preliminary studies
IdentifySensors Biologics is developing saliva-based digital graphene nanosensor technology that it believes can be more sensitive than PCR in detecting COVID-19.
December 12, 2022
Measuring fitness, disease risk without strenuous testing in the lab
University of Cambridge researchers used a deep neural network to process and extract information from raw sensor data and to predict VO2max, an indicator of fitness and marker of heart disease and mortality risk.
December 1, 2022
Chest publication suggests potential for MagArray blood test to stratify lung cancer risk
Its Knodule ID test is a multianalyte assay with algorithmic analysis comprising seven protein biomarkers and six clinical factors.
November 21, 2022
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Glympse to present data on the detection of hepatocellular carcinoma with biosensor platform
In combination, the Glympse assay and a blood biomarker test demonstrated an area under the curve (AUC) of 0.90 in differentiating HCC and cirrhosis patients.
October 25, 2022
ProtonDx secures £365K grant to develop point-of-care tests for porcine lung disease
ProtonDx said this week it has been awarded a £365,000 ($404,238 U.S.) grant from two organizations to develop point-of-care tests for porcine lung diseases.
September 29, 2022
Epicore announces partnership with 3M and Innovize to scale portfolio of wearable hydration solutions
Wearable solutions developer Epicore Biosystems on Thursday announced a partnership with 3M’s Health Care Business and Innovize to scale the development of its sweat-sensing wearable technology.
September 29, 2022
Week in Review: Siemens, Roche, Qiagen launch new testing products; glucose test market to reach $20.4B this year; biosensor developer Know Labs goes public; more
Dear LabPulse.com member,
September 21, 2022
Biosensor developer Know Labs goes public on the NYSE
After the close of trading Thursday, the company announced the pricing of an underwritten public offering of 3.6 million shares at $2.00 per share; it granted to the underwriter a 45-day option to purchase up to 540,000 additional shares at the same price.
September 15, 2022
NanoDx, SkyWater launch nano biosensor
The companies said that as a result of the development, NanoDx is ready to prepare and submit the product for review by the U.S. Food and Drug Administration (FDA) with the aim of eventually commercializing a product based on the technology.
August 25, 2022
Page 1 of 2
Next Page
